Chromosome translocation t(X;18)(p11.2;q11.2) is unique to synovial sarcomas and results in an`in frame' fusion of the SYT gene with the SSX1 or closely-related SSX2 gene. Wild-type SYT and SSX proteins, and the SYT-SSX chimaeric proteins, can modulate transcription in gene reporter assays. To help elucidate the role of these proteins in cell function and neoplasia we have performed immunolabelling experiments to determine their subcellular localization in three cell types. Transient expression of epitope-tagged proteins produced distinctive nuclear staining patterns. The punctate staining of SYT and SYT-SSX proteins showed some similarities. We immunolabelled a series of endogenous nuclear antigens and excluded the SYT and SYT-SSX focal staining from association with these domains (e.g. sites of active transcription, snRNPs). In further experiments we immunolabelled the Polycomb group (PcG) proteins RING1 or BMI-1 and showed that SSX and SYT-SSX proteins, but not SYT, co-localized with these markers. Consistent with this we show that SSX and SYT-SSX associate with chromatin, and also associate with condensed chromatin at metaphase. Noteably, SSX produced a dense signal over the surface of metaphase chromosomes whereas SYT-SSX produced discrete focal staining. Our data indicate that SSX and SYT-SSX proteins are recruited to nuclear domains occupied by PcG complexes, and this provides us with a new insight into the possible function of wild-type SSX and the mechanism by which the aberrant SYT-SSX protein might disrupt fundamental mechanisms controlling cell division and cell fate.
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Keywords: chromosome translocation; SSX; SYT; polycomb; chromatin; nucleus The chromosome translocation t(X;18)(p11.2;q11.2) is a unique cytogenetic marker for the diagnosis of synovial sarcoma. It is observed in approximately 75 ± 80% of these tumours (Sandberg and Bridge, 1994) . The name is a misnomer for these tumours do not originate from synovial membrane, although they do predominently occur in close association with joint structures in the limbs. t(X;18) positive synovial sarcomas have also been described in the tongue, larynx, heart, jaw, pleura, and abdominal wall. The tumours arise in mesenchymal tissue but display the features of epithelial dierentiation including keratins, basal lamina formation, and glandular architecture (Fisher, 1986) . Synovial sarcoma is most prevalent in the 15 ± 40 year age group, and aects both males and females (Enzinger and Weiss, 1995) . The t(X;18) translocation results in the fusion`in frame' of 3' sequences of the SYT (SYnovial sarcoma Translocation) gene on chromosome 18, to 5' sequences of either of two closely-related genes SSX1 or SSX2 (Synovial Sarcoma X chromosome breakpoint) in chromosome band Xp11.2 (Clark et al., 1994; Crew et al., 1995; de Leeuw et al., 1995) (Figure 1 ). The fusion gene is transcribed and translated as a chimaeric SYT-SSX1 or SYT-SSX2 protein, and it is these novel proteins that are considered to underly the pathogenesis of synovial sarcoma. The SSX and SYT genes were unknown until identi®ed as fusion partners in t(X;18), and their functions have yet to be elucidated.
Transcripts of wild-type SYT are expressed in a wide range of human tissues and cell lines including those derived from synovial sarcoma (Clark et al., 1994; J Knight, unpublished observations) . SYT is ubiquitously expressed in early mouse embryogenesis, and in later stages expression becomes con®ned to cartilage tissues, speci®c neuronal cells and some epithelialderived tissues (de Bruijn et al., 1996) . The SYT protein shows few primary structural features. It comprises 387 amino acids rich in glutamine (19%), proline (16%), and glycine (14%) residues, and contains several putative SH2 and SH3 binding domains (Clark et al., 1994) . There is no recognisable DNA binding domain, although recently Brett and coworkers showed that SYT is able to transactivate transcription when targeted to a reporter gene (Brett et al., 1997) . However, the functional signi®cance of this ®nding is unclear.
The identi®cation of SSX1 and SSX2 has led to the cloning of a further three family members (Gure et al., 1997) with very high sequence similarity and unknown function. SSX1 and SSX2 transcripts are abundant in human adult testis, expressed at low levels in the thyroid, and not detectable in other normal tissues (Crew et al., 1995) , although SSX expression during embryogenesis has not been documented. SSX1 and SSX2 encode closely-related proteins of 188 amino acids sharing 81% identity. SSX proteins contain no recognisable DNA binding sequence, but they can act as transcriptional repressors when targeted to a reporter gene (Brett et al., 1997; Lim et al., 1998) . A KruÈ ppel-associated box (KRAB) domain is present at the amino-terminus of SSX proteins (Crew et al., 1995) . Unlike the typical KRAB domains found in KruÈ ppel-type zinc ®nger proteins, the KRAB domain of SSX proteins does not potentiate a potent transcriptional repression eect and does not interact with the KRAB co-repressor TIF1b (Lim et al., 1998) . However, a strong transcriptional repression domain, termed the SSXRD (SSX Repression Domain), is present at the carboxy-terminus of SSX proteins (Lim et al., 1998) .
In the majority of tumours the fusion point between the SYT and SSX genes is consistent with the production of a chimaeric protein in which the Cterminal eight amino acids of SYT are replaced by the seventy-eight C-terminal amino acids of SSX1 or SSX2 (Crew et al., 1995) . The chimaeric protein retains those sequences of SYT shown to possess transactivation potential (Brett et al., 1997) and the SSXRD transcription repression domain of SSX, but lacks the SSX KRAB domain (Figure 1 ). To further understand the normal function of wild-type SYT and SSX proteins and the mechanism by which aberrant SYT-SSX protein could disrupt cell function and lead to neoplasia, we have studied the sub-cellular localization of each protein in immunolabelling experiments. Here we report our observations and conclusions.
We performed immunolabelling experiments on proteins expressed exogenously by transfection of DNA into mammalian cells. We constructed mammalian expression vectors containing the appropriate fulllength cDNA sequences (con®rmed by sequencing) fused to an amino-terminal haemagglutanin (HA) epitope tag to facilitate immunodetection (Figure 1) . Following transient transfection into cells, protein expression and integrity was con®rmed by immunoblotting with an anti-HA monoclonal antibody (mAb; Boehringer) (data not shown). The sub-cellular localization was determined on paraformaldehyde®xed and permeabilized cells by indirect immunofluorescence labelling with anti-HA mAb (see legend to Figure 2 ) that was then localized by imaging 1 mm thick sections. Our rabbit polyclonal antisera to endogenous SYT and SSX failed to show sucient speci®city in these experiments thus necessitating our approach of studying exogenously expressed proteins. Whilst this work was in progress similar approaches towards de®ning the sub-cellular localization of these proteins were undertaken by Brett et al. (1997) and dos Santos et al. (1997) .
In addition to the COS7 cell line, we analysed protein expression in a synovial sarcoma derived cell line CME-1 (Renwick et al., 1995) and in a clonal derivative of the human ®brosarcoma cell line HT1080 designated 2C4 (Saurin et al., 1998) . HA-tagged SYT, SSX1, SSX2, SYT-SSX1 and SYT-SSX2 each localized to the nuclei of these cells, producing distinctive staining patterns (data for CME-1 and 2C4 are shown in Figure 2 ). The protein distributions we describe were consistently observed in experiments repeated three times and in which a minimum of 30 nuclei of each cell line were scored. SYT accumulated in the nucleus as discrete toroidal-shaped foci. The number of foci varied, but averaged six per transfected cell. The nuclear distribution of SYT has previously been described as`speckled' (Brett et al., 1997) and punctate' (dos Santos et al., 1997) . We could not make any distinction between the nuclear distributions of HA-SSX1 and HA-SSX2 proteins ( Figure 2 ). We observed non-uniform microparticulate and diuse staining throughout the nucleus but excluded from the nucleoli. In addition we observed patches of stronger signal that were particularly apparent in 2C4 cells as two prominent foci ( Figure 2 ). The distribution of HA-SYT-SSX1 and HA-SYT-SSX2 in the nucleus produced a distinctive punctate staining. A proportion of the protein accumulated as toroidal-like structures, reminiscent of the pattern of HA-SYT, but SYT-SSX foci were abundant particularly in the nuclei of COS7 and CME-1 cells (Figure 2) . In 2C4 nuclei, we observed two prominent foci ( Figure 2 ) and failed to see any similar signal with HA-SYT.
The nuclear distribution of transiently expressed GFP, VSV, FLAG tagged or untagged synovial sarcoma proteins has been described recently by Brett et al. (1997) and dos Santos et al. (1997) , their data indicating that sub-cellular localization is consistent in the presence or absence of a peptide tag. SYT and Figure 1 Schematic diagram of epitope-tagged proteins. The predicted protein product of the SYT gene is 387 residues in length and has no recognisable sequence motifs. Putative Src-homology domains (SH2/SH3) are shown. SSX genes encode small proteins of 188 residues characterized by an amino-terminal KRAB domain and a carboxy-terminal transcription repression domain (SSXRD). In t(X;18) the point of fusion between SYT and SSX1 or SSX2 is identical. The translated protein comprises (aa 1 ± 379) SYT and (aa 111 ± 188) SSX (Crew et al., 1994) . Transcripts of the reciprocal fusion gene are not detected (Clark et al., 1994) . To facilitate immunolabelling, proteins were expressed`in frame' with an amino-terminal haemagglutanin (HA) epitope (black shading)
SYT-SSX proteins showed a nuclear speckled appearance in all cell lines transfected including NIH3T3, COS1, and HT1080, and similarities between the distribution of the wild-type and chimaeric proteins were emphasised. FLAG-or GFP-tagged SSX produced a diuse nuclear distribution in NIH3T3 cells and COS1 cells. 2C4 cells (and the parent cell line HT1080) have not been used previously in the analysis of SSX distribution. dos Santos and co-workers (1997) showed that endogenous SYT-SSX1 protein in synovial Figure 2 Nuclear localization of the SYT, SSX and SYT-SSX proteins. Expression constructs for HA-SYT, HA-SSX, and HA-SYT-SSX were transiently expressed in 2C4 and CME-1 cells by transfection using the calcium phosphate method. Cells were harvested and ®xed for 10 min (4% (w/v) paraformaldehyde in buer A: 10 mM PIPES pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 2 mM EDTA) and permeabilized (0.5% Triton X100 in buer A, 4 min incubation) after 16 h (2C4) or 36 h (COS7 and CME-1). The proteins were then immunolabelled using antibodies to the HA tag (Boehringer mouse mAb 12CA5 or Autogen Bioclear UK mAb AB101). Non-speci®c staining was reduced by diluting antibodies in 5% calf serum/0.2% ®sh gelatin, the same mix being used for washing away unbound antibody. Primary antibody was incubated for 1 h at room temperature, secondary antibody for 45 min. Images were captured with a BioRad MRC 1000 inverted confocal microscope. The images shown of CME-1 cells represent a projection of multiple confocal optical sections; the images of 2C4 cells represent a single confocal optical section 1 mm thick. Scale bars represent 10 mm in each panel sarcomas and SYT-SSX1 expressed exogenously in transfected cells, have a similar punctate nuclear distribution. Both groups (Brett et al., 1997; dos Santos et al., 1997) suggested that SYT-SSX and SYT produce signals that overlap, but did not provide the data to underscore this assumption and failed to identify any known nuclear structure or domain with which the signals correspond.
To de®ne the nuclear compartment(s) with which SYT, SSX and SYT-SSX proteins associate, we performed double immuno¯uorescence labelling using antibodies against known nuclear antigens to label endogenous proteins and anti-HA antibodies to label exogenously expressed HA-tagged protein in 2C4 cells. We have recently carried out a rigorous analysis of the distribution of nuclear antigens/nuclear structures in 2C4 cells (Saurin et al., 1998) , thus making this an appropriate system to use for the present study. All of the antibodies used have been characterized and validated previously (Saurin et al., 1998 ; see legend to Figure 3 for references).
We found no co-localization or association between SYT-SSX2 and PML nuclear bodies, SC-35`interchromatin granules', small nuclear riboproteins (snRNPs), or p80 coilin and coiled bodies. Similarly we could not demonstrate any association between SYT and PML bodies or snRNPs. These data (not shown) con®rm conclusions drawn from the analysis of other cell lines (Brett et al., 1997; dos Santos et al., 1997) . In addition to these data our results indicate that SYT-SSX2 does not co-localize with polypyrimidine tract binding protein (PTB) (Figure 3a) , and that neither SYT-SSX2, SYT, nor SSX proteins accumulate at sites of active transcription (Figure 3b and data not shown).
Polycomb group proteins form multimeric complexes (PcG bodies) which can be associated with pericentromeric chromatin (Saurin et al., 1998) . Two components of mammalian PcG complexes are RING1 and BMI-1 which interact in vivo , although the total number of PcG gene products is at present unknown. Immuno¯uorescence labelling of endogenous RING1 has previously revealed that 2C4 cells have prominent PcG bodies highly concentrated into two foci per nucleus (Saurin et al., 1998) . These PcG bodies do not co-localize with any of the nuclear antigens screened earlier in this or previous studies (Saurin et al., 1998) . By labelling RING1 as a marker for PcG bodies we have found that the signal for SYT-SSX2 overlaps with the signal for RING1 in all cells examined (Figure 3c and inset; yellow signal) . We have also demonstrated that SYT-SSX1 and SYT-SSX2 colocalize with endogenous BMI-1 (Figure 4d and e) . In addition, partial¯uorescence overlap was observed between SYT-SSX2 and centromere-associated protein structures called kinetochores (labelled with antibody H33; Figure 3d and inset; yellow signal). This is consistent with the recent ®nding that PcG bodies can be juxtaposed with kinetochores bound to pericentromeric heterochromatin (Saurin et al., 1998; Wang et al., 1997) . Thus in interphase 2C4 cells the SYT-SSX2 protein accumulates preferentially with PcG proteins in the vicinity of the centromere. We repeated these immunolabelling experiments with HA-tagged SSX1, SSX2, and SYT transfected into 2C4 cells. There was no association between SYT and BMI-1, as can be seen by the absence of yellow signal in Figure 4a . However, the results with SSX proteins were striking. In addition to the microparticulate staining pattern throughout the nucleus we observed that the two prominent SSX1 or SSX2 signals that we had noted previously co-localized with endogenous BMI-1, as seen by the yellow signals in Figure 4b and c.
These data suggest that the SSX portion of the chimaeric protein is the determinant for targetting the protein within the nucleus, and that SYT-SSX is recruited to the nuclear compartment occupied by PcG complexes. Our results dier from the conclusions of two previous studies which suggested that the SYT portion of the chimaeric protein recruits it to so-called SYT bodies (Brett et al., 1997; dos Santos et al., 1997) . These conclusions were based on some similarities in the immunostaining patterns of SYT and SYT-SSX proteins, but these studies did not present colocalization data for SYT and SYT-SSX. Our data supports the opposite model, whereby SSX is dominant in terms of targetting the sub-cellular localization of the SYT-SSX protein. We are able to form such a conclusion because we can study the co-localization of each individual SYT, SSX, or SYT-SSX protein with a well-de®ned nuclear component, namely the PcG complex.
PcG bodies are known to form distinct nuclear foci, the numbers of which dier from cell type to cell type (Alkema et al., 1997a; Satijn et al., 1997; Saurin et al., 1998) . In 2C4 cells the PcG bodies are highly prominent. In the synovial sarcoma cell line CME-1, endogenous BMI-1 (marking the PcG complexes) appears as dense speckling throughout the nucleus (centre panels in Figure 5 ), thus making the interpretation of images more dicult. However it can be seen Figure 3 Localization of SYT-SSX2 relative to known nuclear structures and domains. HA-SYT-SSX2 was transiently expressed in 2C4 cells and its distribution compared with that of endogenous nuclear antigens. SYT-SSX2 was immunolocalized with a polyclonal antibody against HA (Y11; Autogen Bioclear UK Ltd.) (Green channel, a, b and d) or a monoclonal antibody against HA (red channel, c) and compared with signals obtained with anti-PTB (Huang et al., 1997 ; gift of D Spector), anti-RING1 (ASA3) (Saurin et al., 1998) and anti-H33 (kinetochore antigen; Stuurman et al., 1992 ; gift of A Otte) antibodies. Sites of active RNA transcription were visualized using an anti-BrUTP antibody (Sigma) following in vivo incorporation of the nucleotide analogue bromo-UTP into nascent RNA (protocol according to Wansink et al., 1994) . All images comprise a digital overlay of two optical channels (red and green) obtained from a single optical confocal section (1 mm thick) that exogenous SYT-SSX2 (Figure 5g ) co-localizes with endogenous BMI-1 (Figure 5i , yellow signal), whereas SYT (Figure 5a ) does not co-localize with BMI-1 (Figure 5c ). The data for SSX2 (Figure 5d ) was less clear, since SSX2 was highly expressed throughout the nuclear volume of CME-1 cells (see also Figure 2 , bottom right panel). However we could distinguish a signi®cant association with BMI-1 in regions where SSX2 was most concentrated (Figure 5f ). The heterogeneity of distribution of PcG complexes between cell lines may explain why previous studies, using dierent cell lines, have described SSX proteins as producing a diuse nuclear staining (Brett et al., 1997; dos Santos et al., 1997) .
In Drosophila large multimeric PcG complexes have a fundamental role as a stable repressor system that maintains the embryonic segmentation program of homeotic gene silencing, essentially ensuring the correct execution of developmental programmes (for reviews see Bienz and Muller, 1995; Pirrotta, 1998) . Many PcG proteins lack DNA binding activity and the available evidence suggests they assemble via proteinprotein interactions. These large protein complexes are believed to function epigenetically by modifying higher order chromatin structure (Paro, 1990) . Recent ®ndings indicate strong evolutionary conservation of PcGmediated repression, with several vertebrate homologues now described (for reviews see Gould, 1997; Schumacher and Magnuson, 1997) , but little is known about PcG function in vertebrates.
Speci®c interactions have been de®ned between components of mammalian PcG complexes, including RING1 and BMI-1 (Alkema et al., 1997a; Satijn et al., 1997; Schoorlemmer et al., 1997; Hashimoto et al., 1998) . Although we have shown that SSX and SYT-SSX can be recruited to regions containing RING1 and BMI-1, we have no evidence for a direct interaction between SSX or SYT-SSX with these PcG components. Western blots using antibodies speci®c for RING1 and BMI-1 after co-immunoprecipitation of tagged SSX or SYT-SSX gave negative results, suggesting that SSX and SYT-SSX do not interact directly with RING1 and/or BMI-1 (data not shown). This result is perhaps not surprising since the exact number of mammalian PcG proteins is unknown (in Drosophila the estimate is 30 ± 40 PcG genes) and SSX and SYT-SSX may interact with as yet unidenti®ed components of these complexes. Our coimmunoprecipitation experiments using radio-labelled cell extracts (preliminary data, not shown) showed that both SSX and SYT-SSX interact speci®cally with a 65 kDa protein, the identi®cation of which is currently being investigated.
We have previously reported that in a number of mammalian cell lines PcG bodies remain chromatinassociated throughout mitosis (Saurin et al., 1998) . During mitosis chromatin undergoes condensation, there is a general inhibition of transcriptional activity, and many sequence-speci®c transcription factors are displaced (Martinez-BalbaÂ s et al., 1995) . Given that SSX1, SSX2, and the SYT-SSX chimaeric proteins appear to co-localize with PcG bodies, we wanted to reinforce this ®nding by determining whether these proteins associate with chromatin in mitotic cells. To address this question we transiently expressed HAtagged SYT, SSX1, SSX2, or SYT-SSX2 in COS7 cells, immunolabelled the cells with anti-HA and counterstained the chromatin with propidium iodide ( Figure  6 ). We looked at mitotic cells for evidence of association between the exogenous protein and the condensed chromatin. There was no correlation between SYT and the distribution of chromatin (Figure 6c ). However the microparticulate staining of SSX1 and SSX2 was clearly distributed over the chromatin at mitosis. At prometaphase/metaphase SSX proteins produced dense staining on the chromosomes, presumably accessing sites exposed over the entire surface of the chromosomes (Figures 6f and i) . This highlighted a dierence in the characteristics of wild-type SSX and the chimaeric SYT-SSX. At prometaphase/metaphase SYT-SSX2 signal also correlated with areas of chromatin, but it appeared as discrete foci (Figure 6j and l) similar to the pattern we have observed previously for RING1 and BMI-1 (Saurin et al., 1998) . These observations support the contention that SSX and SYT-SSX proteins are recruited to the vicinity of PcG complexes, and argue against the possibility that SYT-SSX is recruited to the location of wild-type SYT in the nucleus, since wildtype SYT is clearly not a chromatin-associated protein.
The biological signi®cance of the association of SSX and SYT-SSX proteins with the PcG complex is at present unclear, but it would be plausible to propose that there is a connection with the pathogenesis of synovial sarcoma. Many aspects of the function of mammalian PcG proteins are still unknown, but there is increasing evidence that they play a role in regulating cell cycle progression and dierentiation, beyond their role in regulating homeotic boundaries (Schumacher and Magnuson, 1997; van Lohuizen et al., 1998) . Transgenic expression and gene knockout approaches have implicated certain PcG genes in proliferative responses and dierentiation of progenitor cells in the mouse haematopoietic system, for example overexpression of BMI-1 predisposes to the development of lymphomas (CoreÂ et al., 1997; Haupt et al., 1991; van Lohuizen et al., 1991 , van Lohuizen, 1998 . To date there are no examples of human disease-associated chromosome translocations or other somatic mutations that directly disrupt a PcG gene. SSX genes do not share any sequence homology with known PcG genes, but SSX proteins and known PcG proteins all share a common functional phenotype whereby they have the ability to repress transcription when targeted to a reporter gene, and lack speci®c DNA binding domains (Alkema et al., 1997b; Bunker and Kingston, 1994; Satijn et al., 1997; Schoorlemmer et al., 1997; Lim et al., 1998) . Clearly the identi®cation of proteins interacting with SSX and SYT-SSX proteins is a priority.
In this report we have provided evidence that the chimaeric protein SYT-SSX generated by the t(X;18) translocation can be recruited to sites on chromatin, that it can interact with available sites on condensed chromatin at mitosis, and can occupy sites in the vicinity of PcG complexes near centromeres in interphase nuclei. These characteristics seem to be a function of SSX rather than SYT. The interaction of SYT-SSX with condensed chromatin at mitosis diers in at least one respect from wild-type SSX as revealed by their dierent staining patterns on metaphase chromosomes. This may have functional signi®cance. In addition the chimaeric protein may have acquired new functions from SYT which is inappropriately Figure 5 Co-localization of HA-SSX and HA-SYT-SSX with the human Polycomb group complex in CME-1 cells. Epitope-tagged SYT, SSX2 and SYT-SSX2 were transiently expressed in the t(X;18) positive synovial sarcoma cell line CME-1 (see legend to Figure  2 ) and immunolabelled with antibody to the HA tag and Texas Red-conjugated secondary antibody. PcG complexes were visualized (green channel) by labelling the endogenous PcG protein BMI-1 (b, e, h). These images were obtained from a single optical confocal section 1 mm thick. The image in (c, f, and i) is a digital overlay of the two optical channels, indicating where the distribution of proteins overlaps (yellow signal) expressed in the vicinity of PcG complexes and chromatin. Furthermore, the fusion between the SYT and SSX genes puts the expression of the chimaeric protein under the control of the SYT promoter such that the expression of SSX itself is inappropriately regulated within the cell. We have provided a new insight into the possible role that SSX genes play in cell function that should contribute to an understanding of PcG function in vertebrates and to understanding the molecular basis of synovial sarcoma.
